1. The quality of life in patients with at least moderate ischemic mitral regurgitation qualified to cardiosurgery treatment.
- Author
-
PIĄTKOWSKI, RADOSŁAW, KUCHARZ, JAKUB, GAWAŁKO, MONIKA, BUDNIK, MONIKA, WOŁOSIEWICZ, KATARZYNA, KOZUB, BARBARA, KOCHANOWSKI, JANUSZ, GRABOWSKI, MARCIN, and OPOLSKI, GRZEGORZ
- Subjects
CORONARY artery disease ,MYOCARDIAL infarction ,MITRAL valve insufficiency ,QUALITY of life ,QUESTIONNAIRES - Abstract
Background: To assess and compare mid-term outcomes and the quality of life (QoL) in patients with multivessel coronary artery disease (MVD) and moderate ischemic mitral regurgitation (IMR), treated with either coronary artery bypass grafting (CABG; group I) or CABG + mitral annuloplasty (CABG+MA; group II) in 12-months follow-up after surgery. Methods: We prospectively analyzed 74 patients (50.7% female, 66 [67-72] years) with at least moderate IMR, 3-24 weeks after myocardial infarction (MI). The effective regurgitation orifice (ERO) was used for a quantitative IMR assessment. To evaluate QoL we used a Short Form-36 (SF-36) questionnaire. Results: Patients in group II spent more time in the hospital, expired more infection complications and received more often in-hospital complications requiring use amines and intra-aortic balloon pump as compared to those in group I. Analysis of SF-36 showed that all patients treated surgically notable improved their QoL during 12 months of follow-up. Conclusion: We observed a significant improvement in QoL among patients with MVD in 12 months follow-up after surgery irrespective of treatment type. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF